Dear Rebecca,
It might help you (and us) to better understand your exact situation if you asked your doctor what the % of blast cells were in your marrow/peripheral blood at diagnosis and what he considers to be the best therapeutic option in your case.
Usually BC-blast crisis- is determined by more than 30% blast cells present in your marrow and/or peripheral blood.
5%-20% blasts usually signifies that the disease is entering or is already in AP-accelerated phase.
Blast cells at 0-5% is considered CP-chronic phase.
No matter what, your counts should be closely monitored so that if imatinib/Glivec fails to control the disease, then it might be that he would then recommend transplant.
From the information that you have given on this forum,at least from the posts that I have seen, there is no reason to question your diagnosis of Ph+CML in Blast crisis and therefore it is understandable why Prof.Reilly is recommending that you look to transplant, even though you have initially responded well to Glivec 800mg.
I am sure he is very well aware of the current options open to PH+CML diagnosed in Blast crisis and I would be very surprised if you were given the wrong diagnosis...
Current data shows that very few people with CML in Blast Crisis maintain a significantly long term response to Glivec (or other 2nd generation TKI's).
You should ask your doctor if that is why he considers that you will need to consider a transplant in the near future and if a search for a suitably HLA matched donor has already started.
You could also ask the following questions:
1.What was the % of blast cells in your blood/marrow?
2.Was your spleen enlarged and/or were there any other indicators that pointed to your disease being in BC?
3.Why does he think you need a stem cell transplant given your good response so far to imatinib/Glivec?
4.Are there reasons (say from further tests) that he believes that you will not continue to hold your response to imatinib over the long term...
ie is there any evidence of a drug resistant mutation or clonal evolution which would mean you would not hold your response and would not respond to another 2nd generation TKI like nilotinib or desatinib?
5.Should they find a suitably matched HLA donor, what sort of stem cell transplant would he recommend in your case?
6.Would he recommend a reduced intensity transplant (RICsct) like those currently being studied at centres like Hammersmith, Birmingham and Newcastle, amongst other UK transplant centres?
7.If not then what does he consider to be the preferred option for you... and why?
8.What are the number of transplants performed at Sheffield on a yearly basis?
9.Would he support you if you wanted to opt for a RICsct, if not at Sheffield then at another centre?
10.Would he support your seeking a second opinion?
I do hope this list gives you some ideas for questions
Sandy